Johnson & Johnson Unusual Options Activity For July 29
Johnson & Johnson Unusual Options Activity For July 29
Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE:JNJ) revealed 10 unusual trades.
金融巨頭對強生公司採取了明顯的看淡動作。我們對強生公司（紐交所：JNJ）期權歷史進行分析後發現了10次非尋常的交易。
Delving into the details, we found 20% of traders were bullish, while 70% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $117,603, and 6 were calls, valued at $283,044.
進一步了解詳情，我們發現20％的交易者看好，而70％的交易者表現出看淡的趨勢。在我們發現的所有交易中，有4個看跌期權，價值爲117,603美元，6個看漲期權，價值爲283,044美元。
What's The Price Target?
目標價是多少？
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $135.0 to $170.0 for Johnson & Johnson over the last 3 months.
考慮到這些期權的成交量和持倉量，過去3個月裏鯨魚們一直在將強生公司的目標價格範圍定在135.0到170.0美元之間。
Insights into Volume & Open Interest
成交量和持倉量分析
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Johnson & Johnson's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Johnson & Johnson's significant trades, within a strike price range of $135.0 to $170.0, over the past month.
審查成交量和持倉量可以爲股票研究提供關鍵的見解。這些信息在衡量強生公司的期權特定執行價格的流動性和興趣水平方面至關重要。以下是我們在過去一個月內在強生公司重要交易中，涵蓋了執行價格在135.0到170.0美元之間的看漲期權和看跌期權的成交量和持倉量趨勢的快照。
Johnson & Johnson 30-Day Option Volume & Interest Snapshot
強生公司30天期權成交量和持倉量快照
Significant Options Trades Detected:
檢測到重大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | TRADE | BEARISH | 12/18/26 | $15.05 | $13.9 | $14.3 | $170.00 | $100.1K | 15 | 70 |
| JNJ | CALL | TRADE | BEARISH | 08/16/24 | $5.6 | $5.45 | $5.5 | $155.00 | $55.0K | 9.8K | 120 |
| JNJ | CALL | SWEEP | BEARISH | 01/17/25 | $21.85 | $21.45 | $21.5 | $140.00 | $36.5K | 623 | 29 |
| JNJ | PUT | SWEEP | BEARISH | 09/20/24 | $2.42 | $2.39 | $2.4 | $155.00 | $36.4K | 3.8K | 202 |
| JNJ | CALL | SWEEP | BEARISH | 09/20/24 | $1.67 | $1.66 | $1.67 | $165.00 | $35.9K | 7.9K | 481 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ24C | 看漲 | 交易 | 看淡 | 12/18/26 | $15.05 | $13.9 | $14.3 | $170.00 | $100.1K | 15 | 70 |
| JNJ24C | 看漲 | 交易 | 看淡 | 08/16/24 | $5.6 | $5.45 | $5.5 | $155.00 | $55.0K | 9.8千 | 120 |
| JNJ24C | 看漲 | SWEEP | 看淡 | 01/17/25 | $21.85 | $21.45 | 21.5美元 | $140.00 | $36.5K | 623 | 29 |
| JNJ24C | 看跌 | SWEEP | 看淡 | 09/20/24 | $2.42 | $2.39 | $2.4 | $155.00 | 成交量: $36.4K | 3.8K | 202 |
| JNJ24C | 看漲 | SWEEP | 看淡 | 09/20/24 | $1.67 | $1.66 | $1.67 | 165.00美元 | $35.9K | 7.9K | 481 |
About Johnson & Johnson
關於Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
強生（Johnson & Johnson）是全球最大、最多元化的醫療保健公司，業務包括藥品和醫療設備兩個部門。在2023年的消費業務Kenvue剝離後，這兩個部門現在代表公司的全部銷售額。藥品部門專注於以下治療領域：免疫學、腫瘤學、神經學、肺、心臟病和代謝性疾病。地理上，總收入中略超過一半是在美國產生的。
Having examined the options trading patterns of Johnson & Johnson, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
在研究強生公司的期權交易模式後，我們的注意力現在直接轉向了該公司。這個轉變使我們能夠深入研究其當前的市場位置和表現。
Where Is Johnson & Johnson Standing Right Now?
強生公司目前處於什麼位置？
- With a volume of 5,597,868, the price of JNJ is down -1.64% at $158.0.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 78 days.
- JNJ的成交量爲5,597,868美元，股價下跌1.64％，報158.0美元。
- RSI因子暗示底層股票可能被超買。
- 下一個業績預計將在78天內發佈。
Professional Analyst Ratings for Johnson & Johnson
強生公司的專業分析師評級
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $178.8.
過去一個月中，5位行業分析師分享了他們對這隻股票的見解，提出了178.8美元的平均目標價。
- Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $175.
- An analyst from TD Cowen persists with their Buy rating on Johnson & Johnson, maintaining a target price of $185.
- Reflecting concerns, an analyst from Daiwa Capital lowers its rating to Neutral with a new price target of $150.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $215.
- An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Johnson & Johnson, which currently sits at a price target of $169.
- 反映擔憂，RBC Capital的一位分析師將其評級下調至Outperform，並設定新的價格目標爲175美元。
- 來自TD Cowen的分析師堅持他們對強生公司的買入評級，維持185美元的目標價。
- 反映出其擔憂，來自大和資本的分析師將其評級下調至中立並給出了150美元的新目標價。
- 作爲預防措施，Cantor Fitzgerald的一位分析師將其評級下調爲超重，將價格目標設定爲215美元。
- 摩根士丹利的分析師決定維持他們對強生公司的同等權重評級，目前的目標價爲169美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。